Healthpeak Properties (NYSE:DOC – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of $1.79-1.81 for the period, compared to the consensus EPS estimate of $1.79. Healthpeak Properties also updated its FY 2024 guidance to 1.560-1.580 EPS.
Healthpeak Properties Stock Performance
NYSE DOC traded down $0.71 on Friday, hitting $22.29. 8,802,307 shares of the company’s stock traded hands, compared to its average volume of 4,002,954. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.91. Healthpeak Properties has a 1-year low of $15.24 and a 1-year high of $23.26. The firm’s 50-day moving average price is $22.26 and its two-hundred day moving average price is $20.66. The firm has a market capitalization of $15.59 billion, a PE ratio of 47.43, a P/E/G ratio of 3.30 and a beta of 1.14.
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The business had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. During the same quarter in the previous year, the firm posted $0.45 earnings per share. The business’s revenue was up 27.5% on a year-over-year basis. As a group, analysts expect that Healthpeak Properties will post 1.79 EPS for the current year.
Healthpeak Properties Dividend Announcement
Analyst Ratings Changes
DOC has been the subject of several recent research reports. Citigroup lifted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Royal Bank of Canada lifted their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, July 30th. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their target price for the company from $20.00 to $28.00 in a report on Monday, October 21st. Finally, Scotiabank lifted their target price on shares of Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a report on Monday, September 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.
View Our Latest Analysis on DOC
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- NYSE Stocks Give Investors a Variety of Quality Options
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is the Nasdaq? Complete Overview with History
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.